Seelos Therapeutics Inc (SEEL)
0.3405
+0.02
(+5.75%)
USD |
NASDAQ |
Apr 19, 16:00
0.3405
0.00 (0.00%)
After-Hours: 16:25
Seelos Therapeutics Cash from Operations (TTM): -23.91M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.91M |
| September 30, 2023 | -35.09M |
| June 30, 2023 | -40.42M |
| March 31, 2023 | -54.91M |
| December 31, 2022 | -61.60M |
| September 30, 2022 | -66.85M |
| June 30, 2022 | -66.29M |
| March 31, 2022 | -54.79M |
| December 31, 2021 | -49.00M |
| September 30, 2021 | -33.98M |
| June 30, 2021 | -27.66M |
| March 31, 2021 | -25.74M |
| December 31, 2020 | -20.91M |
| September 30, 2020 | -22.70M |
| June 30, 2020 | -21.43M |
| March 31, 2020 | -17.79M |
| December 31, 2019 | -19.30M |
| September 30, 2019 | -21.13M |
| June 30, 2019 | -15.54M |
| March 31, 2019 | -14.14M |
| December 31, 2018 | -8.129M |
| September 30, 2018 | -3.657M |
| June 30, 2018 | -9.369M |
| March 31, 2018 | -9.698M |
| December 31, 2017 | -10.47M |
| Date | Value |
|---|---|
| September 30, 2017 | -10.70M |
| June 30, 2017 | -8.531M |
| March 31, 2017 | -9.499M |
| December 31, 2016 | -13.07M |
| September 30, 2016 | -11.67M |
| June 30, 2016 | -17.41M |
| March 31, 2016 | -22.78M |
| December 31, 2015 | -22.64M |
| September 30, 2015 | -30.45M |
| June 30, 2015 | -27.93M |
| March 31, 2015 | -23.95M |
| December 31, 2014 | -18.02M |
| September 30, 2014 | -7.89M |
| June 30, 2014 | -8.02M |
| March 31, 2014 | -8.485M |
| December 31, 2013 | -15.06M |
| September 30, 2013 | -18.81M |
| June 30, 2013 | -17.50M |
| March 31, 2013 | -15.99M |
| December 31, 2012 | -14.38M |
| September 30, 2012 | -14.07M |
| June 30, 2012 | -13.96M |
| March 31, 2012 | -12.45M |
| December 31, 2011 | -9.721M |
| September 30, 2011 | -9.238M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-66.85M
Minimum
Sep 2022
-15.54M
Maximum
Jun 2019
-35.74M
Average
-27.66M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
| 180 Life Sciences Corp | -10.92M |
| Acurx Pharmaceuticals Inc | -9.801M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |